Johnson & Johnson and Crucell NV today announced an agreement whereby Johnson & Johnson, through an affiliate, would acquire all outstanding equity of Crucell that it does not already own for approximately euro 1.75 billion in a recommended cash tender offer.
Johnson & Johnson to acquire all outstanding equity of Crucell for euro 1.75 billion